WebSep 10, 2024 · New Zealand markets close in 2 hours 21 minutes. NZX 50. +2.74 (+0.02%) WebSyros Pharmaceuticals, Inc. (SYRS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 6 hours 59 minutes Dow Futures Nasdaq Futures Russell 2000 Futures … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock discussion in Yahoo … Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Syros Pharmaceuticals, … Find out the direct holders, institutional holders and mutual fund holders for … See the company profile for Syros Pharmaceuticals, Inc. (SYRS) including … See Syros Pharmaceuticals, Inc. (SYRS) stock analyst estimates, including … Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call … Find out all the key statistics for Syros Pharmaceuticals, Inc. (SYRS), including … View the basic SYRS option chain and compare options of Syros … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and …
TYME stock surges on merger agreement with Syros …
WebApr 6, 2024 · Get Syros Pharmaceuticals Inc (SYRS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebDec 13, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for SYRS is 51.5.... head on collision in arizona
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a ...
WebSyros Pharmaceuticals Inc. (SYRS) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.42% SPY 0.17% QQQ 0.55% Trending RIOT 14.56% AUPH 10.18% CRMD 9.44% WW 50.61% SNOW 6.27% SOL.X 12.85% TGTX 18.10% ZIM 12.88% JNUG 4.91% HKD 19.77% More Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. … WebJun 8, 2024 · Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or monthly formats back to when Syros Pharmaceuticals, Inc. stock was issued. WebSep 23, 2024 · Syros Pharmaceuticals, Inc. (SYRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. head on collision las vegas